Showing results (11-20 of 143) with videos related to
Sort By:
Pageof 15
Cellular Immunology|September 1, 1986
Histamine inhibits interferon-gamma production via suppression of interleukin 2 synthesisM Dohlsten, H O Sjögren, R CarlssonCellular Immunology|October 1, 1987
Histamine acts directly on human T cells to inhibit interleukin-2 and interferon-gamma productionM Dohlsten, H O Sjögren, R CarlssonCellular Immunology|November 1, 1985
Histamine modulates the production of interferon-gamma and interleukin-2 by mitogen-activated human mononuclear blood cellsR Carlsson, M Dohlsten, H O SjögrenCancer Gene Therapy|November 4, 2000
Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumorO Björkdahl, M Dohlsten, H O SjögrenCellular Immunology|November 1, 1996
TCR alpha beta+ anti-tumor cytolytic T lymphocytes express NKR-P1 whilethe anti-tumor activity of TCR gamma delta+ T lymphocytes is not correlated to NKR-P1 expressionU Yrlid, E Petersson, M Dohlsten, et al.Immunology|October 10, 1998
ICAM-1 costimulation induces IL-2 but inhibits IL-10 production in superantigen-activated human CD4+ T cellsT Labuda, J Wendt, G Hedlund, et al.Cancer Immunology, Immunotherapy : CII|August 1, 1995
Enhanced and prolonged efficacy of superantigen-induced cytotoxic T lymphocyte activity by interleukin-2 in vivoH Belfrage, M Dohlsten, G Hedlund, et al.Immunology|February 1, 1997
Prevention of superantigen-induced down-regulation of T-cell mediated cytotoxic activity by IL-2 in vivoH Belfrage, M Dohlsten, G Hedlund, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
Identification of a CD28 response element in the CD40 ligand promoterE Parra, T Mustelin, M Dohlsten, et al.Cancer Immunology, Immunotherapy : CII|April 1, 1997
Prevention of superantigen-induced tolerance in vivo by interleukin-2 treatmentH Belfrage, M Dohlsten, G Hedlund, et al.Pageof 15